183 related articles for article (PubMed ID: 10640699)
1. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.
Minchiotti G; Parisi S; Liguori G; Signore M; Lania G; Adamson ED; Lago CT; Persico MG
Mech Dev; 2000 Feb; 90(2):133-42. PubMed ID: 10640699
[TBL] [Abstract][Full Text] [Related]
2. A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO.
Lee GH; Fujita M; Takaoka K; Murakami Y; Fujihara Y; Kanzawa N; Murakami KI; Kajikawa E; Takada Y; Saito K; Ikawa M; Hamada H; Maeda Y; Kinoshita T
J Cell Biol; 2016 Dec; 215(5):705-718. PubMed ID: 27881714
[TBL] [Abstract][Full Text] [Related]
3. Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.
Colas JF; Schoenwolf GC
Gene; 2000 Sep; 255(2):205-17. PubMed ID: 11024280
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human Cryptic with a hydrophilic extension.
Watanabe K; Nagaoka T; Strizzi L; Mancino M; Gonzales M; Bianco C; Salomon DS
Biochim Biophys Acta; 2008 Dec; 1778(12):2671-81. PubMed ID: 18930707
[TBL] [Abstract][Full Text] [Related]
5. Role of the EGF-CFC gene cripto in cell differentiation and embryo development.
Minchiotti G; Parisi S; Liguori GL; D'Andrea D; Persico MG
Gene; 2002 Apr; 287(1-2):33-7. PubMed ID: 11992720
[TBL] [Abstract][Full Text] [Related]
6. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
[TBL] [Abstract][Full Text] [Related]
7. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration.
Watanabe K; Bianco C; Strizzi L; Hamada S; Mancino M; Bailly V; Mo W; Wen D; Miatkowski K; Gonzales M; Sanicola M; Seno M; Salomon DS
J Biol Chem; 2007 Oct; 282(43):31643-55. PubMed ID: 17720976
[TBL] [Abstract][Full Text] [Related]
8. Cripto: a tumor growth factor and more.
Adamson ED; Minchiotti G; Salomon DS
J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442
[TBL] [Abstract][Full Text] [Related]
9. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
[TBL] [Abstract][Full Text] [Related]
10. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
[TBL] [Abstract][Full Text] [Related]
11. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
[TBL] [Abstract][Full Text] [Related]
12. Cripto as a target for cancer immunotherapy.
Hu XF; Xing PX
Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
Wu Z; Li G; Wu L; Weng D; Li X; Yao K
BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
[TBL] [Abstract][Full Text] [Related]
14. PGAP6, a GPI-specific phospholipase A2, has narrow substrate specificity against GPI-anchored proteins.
Lee GH; Fujita M; Nakanishi H; Miyata H; Ikawa M; Maeda Y; Murakami Y; Kinoshita T
J Biol Chem; 2020 Oct; 295(42):14501-14509. PubMed ID: 32816994
[TBL] [Abstract][Full Text] [Related]
15. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
16. The murine cripto gene: expression during mesoderm induction and early heart morphogenesis.
Dono R; Scalera L; Pacifico F; Acampora D; Persico MG; Simeone A
Development; 1993 Aug; 118(4):1157-68. PubMed ID: 7916676
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes.
Liguori G; Tucci M; Montuori N; Dono R; Lago CT; Pacifico F; Armenante F; Persico MG
Mamm Genome; 1996 May; 7(5):344-8. PubMed ID: 8661720
[TBL] [Abstract][Full Text] [Related]
19. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
20. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
